In 562 patients with non-metastatic rectal cancer, who received pRCT and underwent total mesorectal excision, Das et al. [21] confirmed that CEA level (>0.25 ng/mL) predicted tumor downstaging along with circumferential extent and distance of tumor from the anal verge. Here, CEACAM5 is linked to rectal cancer.